Related Experiment Video
Updated: Jan 24, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
Development of a rapid antiviral screening assay based on eGFP reporter virus of Mayaro virus
Xiaodan Li1, Hongqing Zhang2, Yanan Zhang2
1Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China; Hunan Normal University School of Medicine, Changsha, 410081, China.
Abstract:
Mayaro virus (MAYV) is a neglected mosquito-borne alphavirus that causes illness similar to Chikungunya (CHIKV), Dengue (DENV) and Zika virus (ZIKV). Currently, there is no specific treatment or vaccine against MAYV infection. To develop an efficient antiviral screening assay for MAYV, we constructed the infectious clones of MAYV strain BeAr 20290 and its eGFP reporter virus. The reporter virus exhibited high replication capacity indistinguishable with the wild type MAYV, and was genetically stable within at least five rounds of passages in BHK-21 cell. The expression of eGFP correlated well with the viral replication. Using the known inhibitor ribavirin, we confirmed that the MAYV-eGFP reporter virus could be used for antiviral screening to identify the specific inhibitors against MAYV. Using the MAYV-eGFP based antiviral assay, we found that the compound 6-Azauridine which had antiviral activity against CHIKV and SFV, showed a significant inhibitory effect on MAYV replication.
Insights
Mayaro virus (MAYV) infection lacks specific treatments. Researchers developed a Mayaro virus eGFP reporter assay for efficient antiviral screening, identifying 6-Azauridine as a potential inhibitor.
Area of Science:
- Virology
- Infectious Diseases
- Drug Discovery
Background:
- Mayaro virus (MAYV) is a neglected mosquito-borne alphavirus causing symptoms similar to Chikungunya (CHIKV), Dengue (DENV), and Zika virus (ZIKV).
- There are currently no specific treatments or vaccines available for MAYV infection, highlighting an urgent need for therapeutic interventions.
Purpose of the Study:
- To develop and validate an efficient antiviral screening assay for Mayaro virus (MAYV).
- To identify potential novel inhibitors against MAYV replication using the developed assay.
Main Methods:
- Construction of infectious clones for Mayaro virus (MAYV) strain BeAr 20290 and a genetically engineered eGFP reporter virus.
- Validation of the MAYV-eGFP reporter virus for genetic stability and replication capacity in BHK-21 cells.
- Confirmation of assay utility using ribavirin as a known inhibitor and screening of compounds, including 6-Azauridine.
Main Results:
- The MAYV-eGFP reporter virus demonstrated high replication capacity, comparable to wild-type MAYV, and maintained genetic stability over multiple passages.
- eGFP expression levels directly correlated with viral replication, confirming its utility as a reporter.
- The assay successfully identified 6-Azauridine, a compound previously known to be active against CHIKV and SFV, as a significant inhibitor of MAYV replication.
Conclusions:
- The developed Mayaro virus (MAYV)-eGFP reporter virus serves as a robust and efficient tool for antiviral drug screening.
- The compound 6-Azauridine exhibits significant antiviral activity against MAYV, representing a promising candidate for further therapeutic development.
More Related Videos
10:16High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
Published on: October 30, 2021
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
Related Concept Videos
What are Viruses?
Introduction to Virus
Viruses of Archaea
Viruses with RNA Genomes
Intracellular Movement of Viruses and Bacteria
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...